PGNX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Progenics Pharmaceuticals Inc's quarterly common stock increased from Dec. 2013 ($0.08 Mil) to Mar. 2014 ($0.09 Mil) but then stayed the same from Mar. 2014 ($0.09 Mil) to Jun. 2014 ($0.09 Mil).
Progenics Pharmaceuticals Inc's annual common stock increased from Dec. 2011 ($0.04 Mil) to Dec. 2012 ($0.06 Mil) and increased from Dec. 2012 ($0.06 Mil) to Dec. 2013 ($0.08 Mil).
Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.
The par value of common stocks is meaningless. It is usually set at an absurdly low number.
Progenics Pharmaceuticals Inc Annual Data
Progenics Pharmaceuticals Inc Quarterly Data